Photo: Dario Trimarchi (Flickr)
After dozens died and many more were injured from a meningitis outbreak caused by tainted steroid injections, proposed tougher regulations could cause problems for compounding pharmacies.
The tainted steroid injections came from the New England Compounding Center and Dr. Amy Peak, Director of Drug Information Services at Butler University, says that facility was operating differently than typical compounding pharmacies and typical compounding pharmacies operate on a small scale.
“It just gives an individual drug to an individual patient when a traditionally manufactured drug is not available or something that a patient needed isn‘t something that is supplied through a typical drug manufacturing facility,” Peak says.
She says there does need to be different types of regulation for places that operate on a larger scale and make more high-risk products.
Peak says the NECC was operating more for resale purposes and was making a product with a much higher risk than most compounding pharmacies would make.
Peak says increasing regulation for compounding pharmacies across the board could lead to some facilities going out of business.